Consistently, co-culture with FCRL5 CAR-T cells promoted considerable lysis (Fig. 2i, j) and increased TNF-α and IFN-γ production (Fig. 2k) of these BMMCs, suggesting their therapeutic potential for patients with MM exhibiting FCRL5 antigen expression. This evidence concerns the gene FCRL5 and Miyoshi myopathy.